|
 |
Allergy and Asthma > Antibody (Also Called An Immunoglobulin.)
The following information is about Antibody (Also Called An Immunoglobulin.).
Antibody (Also Called An Immunoglobulin.) Defined
A complex protein that is manufactured by lymphocytes to neutralize or destroy an antigen or foreign protein. Many types of antibodies are protective, however, inappropriate or excessive formation of antibodies may lead to illness.
This definition is in context to Allergy and Asthma. See more contextual defintions for Antibody (Also Called An Immunoglobulin.).
JapanToday: Japan News and Discussion ジャパントゥデイ:日本のニュースを英語で読む
Published July 4, 2009, 3:01 pm, Japan Today
A large-scale antibody test will be conducted on the new H1N1 influenza, ahead of an anticipated second wave of the new flu later this year, at an Osaka Prefecture school hit in May by Japan’s worst group infection, prefectural government officials said Saturday.
Influenza pandemic crosses alarming tipping point
Published July 4, 2009, 10:13 am, Yehey!
THE occurrence of large numbers of people falling ill at or around the same time is one reason why pandemics are disturbing, with ...
Over 7 thousand sex workers, club dancers found with STD
Published July 4, 2009, 9:00 am, The Freeman
More than 7,000 women who work as commercial sex workers, dancers or entertainers in different nightclubs and beer joints in Cebu City have been found positive of sexually-transmitted diseases.
Influenza pandemic crosses alarming tipping point
Published July 4, 2009, 8:05 am, The Manila Times
THE occurrence of large numbers of people falling ill at or around the same time is one reason why pandemics are disturbing, with a potential to temporarily overburden the capacity of government and health services to cope with a crisis.
ThromboGenics And BioInvent Start Recruitment Of Second 100 Patient Cohort In Phase II DVT Prophylaxis Study With TB-402
Published July 4, 2009, 4:09 am, Medical News Today
ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce that they have started recruitment of a second cohort of patients for their Phase II trial of TB-402. This follows completion of recruitment of the first cohort of 100 patients ahead of schedule.
Deadly Leukemia Stem Cells Found And Eliminated By New Targeted Therapy
Published July 4, 2009, 3:09 am, Medical News Today
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer.
Drexel receives nanotech funds
Published July 3, 2009, 10:27 am, The Triangle Online
Nanotechnology promises to create advances in fields ranging from health care to consumer products, introducing applications that could help locate target, and destroy cancer cells as well as ridding contaminants from the environment. This past month, the Nanotechnology Institute announced a total of $2 million to be awarded to 30 scientists from five different universities and institutions ...
Undiagnosed Celiac Disease Associated With Nearly Quadrupled Mortality
Published July 3, 2009, 4:08 am, Medical News Today
Celiac disease, an immune system reaction to gluten in the diet, is over four times more common today than it was 50 years ago, according to findings of a Mayo Clinic study published this month in the journal Gastroenterology.
ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402
Published July 3, 2009, 3:59 am, redOrbit
LEUVEN, Belgium and LUND, Sweden, July 3 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce that they have started recruitment of a second cohort of patients for their Phase II trial of TB-402.
New Targeted Therapy Finds And Eliminates Deadly Leukemia Stem Cells
Published July 2, 2009, 9:23 pm, Science Daily
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia, a notoriously treatment-resistant blood cancer. The study describes exciting preclinical studies in which a new therapeutic approach selectively attacks human cancer cells grown in the lab and in animal models of leukemia.
Are you looking for additional Allergy and Asthma > Antibody (also Called An Immunoglobulin.) news? Try our new "Antibody (also Called An Immunoglobulin.) News Focus" area.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Antibody (Also Called An Immunoglobulin.). If you would like to find related tags we recommend Tag Patterns > Antibody (Also Called An Immunoglobulin.)
Off-site Antibody (also Called An Immunoglobulin.) Research Links
If you still need additional information on Antibody (also Called An Immunoglobulin.) then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
- A9 > Antibody (Also Called An Immunoglobulin.)
- Alexa > Antibody (Also Called An Immunoglobulin.)
- Anti-Aging Revolution > Antibody (Also Called An Immunoglobulin.)
- DMOZ > Antibody (Also Called An Immunoglobulin.)
- Feeds Filtered > Antibody (Also Called An Immunoglobulin.)
- Google > Antibody (Also Called An Immunoglobulin.)
- News Meme > Antibody (Also Called An Immunoglobulin.)
- Nuah: News > Antibody (Also Called An Immunoglobulin.)
- The Feed Directory > Antibody (Also Called An Immunoglobulin.)
- OBP > Antibody (Also Called An Immunoglobulin.)
- Open Tag Directory > Antibody (Also Called An Immunoglobulin.)
- Podzy > Antibody (Also Called An Immunoglobulin.)
- Yahoo > Antibody (Also Called An Immunoglobulin.)
Allergy and Asthma Topics
Everything you need to know about Allergy and Asthma
Allergy and Asthma
If you know the Allergy and Asthma Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Allergy-and-Asthma.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
License
This work is licensed under Creative Commons.